Literature DB >> 16549390

Fully automatic external defibrillators in acute care: Clinicians' experiences and perceptions.

Helen C Hancock1, Alun Roebuck, Martyn Farrer, Steve Campbell.   

Abstract

BACKGROUND: Fully automatic external defibrillators (FAEDs) reduce the time to defibrillation [Martinez-Rubio A, Kanaan N, Borggrefe M, Block M, Makijarvi M, Fedele F, et al. Advances in treating in-hospital cardiac arrest: safety and effectiveness of a new automatic external cardioverter-defibrillator. J Am Coll Cardiol 2003;41(4):627-32; Mattioni T, Kanaan N, Riggio D, Bahu M, Lin D, Welch S, et al. Performance of an automatic external-cardioverter-defibrillator algorithm in the discrimination of supraventricular from ventricular tachycardia. Am J Cardiol 2003;91:1323-6] and improve outcomes [Martinez-Rubio A, Kanaan N, Borggrefe M, Block M, Makijarvi M, Fedele F, et al. Advances in treating in-hospital cardiac arrest: safety and effectiveness of a new automatic external cardioverter-defibrillator. J Am Coll Cardiol 2003;41(4):627-32]. There is, however, no guidance or standard about their use in the UK. This paper presents the results of a study, which explored clinicians' experiences and perceptions of using FAEDs in acute care in the UK. AIMS: This study sought to understand clinicians' experiences and perceptions of the use of FAEDs in acute care and their impact on decision making.
METHODS: Using a qualitative approach, 43 nurses and four physicians were included in a trial of FAEDs in a Coronary Care Unit (CCU) and cardiology ward during 2004. Semi-structured interviews were conducted with nurses and physicians prior to and following the trial. Data were analysed using thematic analysis [Attride-Stirling J, Thematic networks: an analytic to research. Qual Res 2001;1(3):385-405].
RESULTS: Decision control, safety, a lack of confidence in the technology, previous experience and concerns about the psychological affect on patients affected clinicians' decision making and limited the use of the FAED.
CONCLUSION: Despite reported benefits of the FAED [Martinez-Rubio A, Kanaan N, Borggrefe M, Block M, Makijarvi M, Fedele F, et al. Advances in treating in-hospital cardiac arrest: safety and effectiveness of a new automatic external cardioverter-defibrillator. J Am Coll Cardiol 2003;41(4):627-32; Mattioni T, Kanaan N, Riggio D, Bahu M, Lin D, Welch S, et al. Performance of an automatic external-cardioverter-defibrillator algorithm in the discrimination of supraventricular from ventricular tachycardia. Am J Cardiol 2003;91:1323-26], personal and contextual issues affected the clinicians' decision making. More and better understanding about how FAEDs and their context of use may challenge established practice is required in order that it is utilised in the most effective way.

Entities:  

Mesh:

Year:  2006        PMID: 16549390     DOI: 10.1016/j.ejcnurse.2006.01.005

Source DB:  PubMed          Journal:  Eur J Cardiovasc Nurs        ISSN: 1474-5151            Impact factor:   3.908


  3 in total

1.  Defibrillation and resuscitation in a piglet model of pediatric ventricular fibrillation following AHA 2005 guidelines.

Authors:  Zhengyu Zhou; Yubin Wang; Huiying Zhou; Meng Huang; Huiting Liu; Chengtai Hsieh; Zhimou Xue
Journal:  Indian J Pediatr       Date:  2010-08-26       Impact factor: 1.967

2.  'It is not going to change his life but it has picked him up': a qualitative study of perspectives on long term oxygen therapy for people with chronic obstructive pulmonary disease.

Authors:  Juliet Goldbart; Abebaw Mengistu Yohannes; Ryan Woolrych; Susan Caton
Journal:  Health Qual Life Outcomes       Date:  2013-07-25       Impact factor: 3.186

3.  Diagnostic accuracy and usability of the EMBalance decision support system for vestibular disorders in primary care: proof of concept randomised controlled study results.

Authors:  Doris-Eva Bamiou; Dimitris Kikidis; Thanos Bibas; Nehzat Koohi; Nora Macdonald; Christoph Maurer; Floris L Wuyts; Berina Ihtijarevic; Laura Celis; Viviana Mucci; Leen Maes; Vincent Van Rompaey; Paul Van de Heyning; Irwin Nazareth; Themis P Exarchos; Dimitrios Fotiadis; Dimitrios Koutsouris; Linda M Luxon
Journal:  J Neurol       Date:  2021-10-20       Impact factor: 6.682

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.